Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 215Precursor Cell Lymphoblastic Leukemia-Lymphoma 188Lymphoma, Large B-Cell, Diffuse 172Leukemia 102Burkitt Lymphoma 91Lymphoma, Non-Hodgkin 89Lymphoma, Follicular 78Lymphoma, Mantle-Cell 53Neuroblastoma 51Hodgkin Disease 46Central Nervous System Neoplasms 42Sarcoma 37Lymphoma, B-Cell 31Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30Lymphoma, Large-Cell, Anaplastic 29Recurrence 28Lymphoma, T-Cell, Peripheral 28Lymphoma, Large-Cell, Immunoblastic 27Rhabdomyosarcoma 25Neoplasms 25Multiple Myeloma 24Medulloblastoma 22Lymphoma, B-Cell, Marginal Zone 22Leukemia, Lymphocytic, Chronic, B-Cell 21Leukemia, Biphenotypic, Acute 21Brain Neoplasms 20Sarcoma, Ewing 18Retinoblastoma 18Lymphoma, T-Cell 17HIV Infections 17

Interventions

mirdametinib 1Vincristine 1Timolol 1Sirolimus 1Sildenafil Citrate 1Ointments 1Mupirocin 1Lasers, Dye 1Everolimus 1Bioseal 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Vascular Malformations × Vincristine × Clear all
NCT02110069 2023-09-21

A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

Boston Children's Hospital

Phase 2 Terminated
4 enrolled 8 charts

Tufted angioma, Kaposiform Hemangioendothelioma, Hemangioendothelioma, Vascular Malformations, Kasabach-Merritt Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡